Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old, of any gender
- People who have been diagnosed with invasive breast cancer, regardless of the specific type or biological features of the tumour
- People who have finished standard treatments such as surgery, radiotherapy, and/or chemotherapy no more than 3 months ago — or, for certain follow-on treatments (such as chemotherapy, PARP inhibitors, immunotherapy, or targeted treatments given after initial chemotherapy), those treatments must have started less than 3 months ago
- People who have a good enough understanding of French to complete the study questionnaires
- People who have given their informed, written, and explicit consent to participate
- People who are enrolled in the French Social Security system
- People who are willing and able to attend scheduled visits and follow the study procedures
Who may not be able to join:
- People who are already receiving specialised oncosexology care (note: a single past consultation without ongoing treatment, or the use of local vaginal treatments, does not automatically exclude someone — confirm with trial site)
- People whose cancer has spread to other parts of the body (metastatic disease)
- People who are under legal guardianship, curatorship, or a court-ordered protection measure in France
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Véronique D'HONDT, Dr, Institut du Cancer de Montpellier (ICM)
Phone: 04 67 61 31 02
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of the quality of sexual life of patients in the intervention arm and patients in the control arm
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.